MALIGNANCY
Clinical trials for MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new MALIGNANCY trials appear
Sign up with your email to follow new studies for MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental therapy targets deadly Virus-Linked Castleman's disease
Disease control OngoingThis study looks at a rare, often fatal disease called KSHV-associated multicentric Castleman's disease (MCD), caused by a virus. Researchers want to understand how the disease works and test several experimental drug combinations, including zidovudine, valganciclovir, bortezomib…
Matched conditions: MALIGNANCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
CAR-T immune recovery study withdrawn before enrollment
Knowledge-focused TerminatedThis study was designed to track how the immune system recovers after CAR-T cell therapy and to test a pneumococcal vaccine given six months later. It planned to enroll 50 adults with blood cancers or solid tumors. However, the study was withdrawn before any participants were enr…
Matched conditions: MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC